5月21日，宝济药业-B盘中下跌5.02%，报25.36港元/股，成交额3535.91万港元。
宝济药业-B所在的生物科技行业中，板块整体表现偏强，个股中，康方生物涨5.91%，荣昌生物涨4.31%，信达生物涨2.96%，百济神州涨1.93%，三生制药涨0.36%。
公司简介：上海宝济药业股份有限公司专注于重组蛋白药物和抗体药物的产业化与商业化，在上海建设了符合cGMP标准的生产基地，覆盖哺乳动物细胞表达系统及大肠杆菌/酵母表达系统的原液生产线，以及水针剂、冻干粉针剂和一次性预灌封制剂的成品生产线。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.